跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SomniCare - melatonin prolonged-release tablets - TGA Drug Approval Details
Approvals
/
TGA
/
SomniCare - melatonin prolonged-release tablets
Approved
STANDARD
SomniCare - melatonin prolonged-release tablets
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1e663766b0c99882
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
1e663766b0c99882
Product Name
SomniCare - melatonin prolonged-release tablets
Artg Id
422124
Artg Name
SomniCare - melatonin prolonged-release tablets
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2023-09-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ef2c0d61d41a5533569da87b7d6235cd.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/988a9a659c519af6c9c1de2e9c01d708.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1e663766b0c99882
Type
Standard
Back to TGA Approvals